Position in EXEL
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$7,678,382
-$739,826 QoQ
Shares Held
179,025
-6.8% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
1.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Derivatives in EXEL
reported options exposure · as of Jun 30, 2022CallValue
$1,821,750
CallShares
87,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Sargent Investment Group, LLC holds $8,795,985 across 5 Biotechnology names. EXEL ranks #1 (87.3% of the industry book) .
All Filings in EXEL
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,678,382 | 179,025 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $8,418,208 | 192,065 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,020,873 | 194,210 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,001,797 | 204,215 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,033,607 | 217,595 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $7,233,159 | 217,212 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $6,026,757 | 232,245 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $5,457,850 | 242,895 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $6,608,093 | 278,470 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $7,109,436 | 296,350 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $6,511,190 | 297,995 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,810,491 | 304,055 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $6,084,161 | 313,455 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $4,658,978 | 290,460 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $4,435,244 | 282,860 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $1,821,750 | 87,500 | Call | Sole | 2022-07-26 | |
| 2022-06-30 | $5,448,281 | 261,685 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $1,133,500 | 50,000 | Call | Sole | 2022-05-06 | |
| 2022-03-31 | $5,333,117 | 235,250 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $5,418,557 | 296,420 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,430,309 | 209,570 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,826,132 | 484,420 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $11,257,726 | 498,350 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $9,407,912 | 468,755 | Shares | Sole | 2021-02-10 | |
| 2020-12-31 | $401,400 | 20,000 | Call | Sole | 2021-02-10 | |
| 2020-09-30 | $12,838,328 | 525,085 | Shares | Sole | 2020-11-12 | |
| 2020-09-30 | $489,000 | 20,000 | Call | Sole | 2020-11-12 | |
| 2020-06-30 | $12,570,923 | 529,525 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $9,932,582 | 576,805 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||